Global Non-Invasive Aesthetic Treatment Market is valued at approximately USD 16.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.36% over the forecast period 2024-2032. Non-invasive aesthetic treatments encompass a variety of cosmetic procedures designed to enhance physical appearance without surgical intervention. These treatments utilize technologies such as lasers, ultrasound, radiofrequency, and injectables such as dermal fillers and Botox to address cosmetic concerns such as wrinkles, sagging skin, and excess fat. Characterized by minimal downtime, reduced risk, and lower discomfort compared to surgical options, these treatments aim to boost self-confidence and promote well-being.
The Global Non-Invasive Aesthetic Treatment Market for non-invasive aesthetic treatments has seen significant growth driven by increasing number of non-surgical aesthetic procedures performed and growing awareness about cosmetic treatments across the world. People are increasingly opting for treatments such as laser hair removal, Botox, and dermal fillers, attracted by their minimal recovery time and reduced risk compared to surgical options. The growing influence of social media and celebrity endorsements also plays a crucial role in boosting demand. In addition, technological advancements in treatment devices made these treatments more accessible and affordable, which are anticipated to create lucrative opportunities for the market. However, high cost of advanced treatment technologies is going to impede the overall demand for the market during the forecast period 2024-2032.
The key regions considered for the Global Non-Invasive Aesthetic Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America held the largest market share in terms of revenue owing to improved medical facilities, rising demand for non-invasive aesthetic treatments, and a growing geriatric population. The region's well-established healthcare infrastructure and advanced medical devices also contribute to market growth. Furthermore, Asia-Pacific is poised to witness significant growth, driven by rising disposable incomes and improving living standards, leading to increased consumer spending on non-invasive aesthetic procedures.
Major market players included in this report are:
AbbVie Inc.
Cynosure Inc.
HTM Eletronica
Sisram Medical Ltd.
Lumenis Ltd.
Fotona
MerzPharma
Bausch Health Companies Inc.
Candela Corporation.
Cutera
The detailed segments and sub-segment of the market are explained below:
By Procedure:
Injectables
Skin Resurfacing
Others
By Gender:
Female
Male
By Age Group:
13 to 39
40 to 54
55 to 69
Age 70 and Over
By End User:
Specialty and Dermatology Clinics
Hospitals
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
